Woodbury, NY, United States of America

Irwin J Pachter

This inventor holds 1 USPTO granted patent. Top assignee: Endo Laboratories, Inc.. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irwin J Pachter. Retrieved from https://idiyas.com/inventor/irwin-j-pachter-o3fa98cu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Certainly! Here is an article about inventor Irwin J Pachter:

Title: The Innovator Irwin J Pachter: Pioneering Tris[tetrahydroisoquinoline] Compounds

Introduction:

Irwin J Pachter, a notable inventor hailing from Woodbury, NY, has left an indelible mark in the field of pharmaceuticals with his groundbreaking patent on Tris[tetrahydroisoquinoline] compounds. With a strong focus on healthcare advancements, Pachter's work has revolutionized clot inhibition and dissolution in mammals.

Latest Patents:

Irwin J Pachter's most prominent patent is for Tris[tetrahydroisoquinoline] compounds, which are instrumental in preventing and dissolving blood clots in mammals. This innovation has paved the way for advanced treatment modalities in cardiovascular health and anticoagulation therapies.

Career Highlights:

As a key figure at Endo Laboratories, Inc., Pachter has demonstrated his prowess in pharmaceutical research and development. His dedication to scientific inquiry and problem-solving has led to tangible outcomes that benefit both the medical community and patients alike.

Collaborations:

Pachter's collaborative spirit is exemplified through his partnership with esteemed coworker Parthasarathi Rajagopalan. Together, they have synergized their expertise to push the boundaries of pharmaceutical innovation, fostering a culture of excellence and achievement at Endo Laboratories, Inc.

Conclusion:

In conclusion, Irwin J Pachter emerges as a visionary inventor whose contributions to the field of pharmaceuticals have made a significant impact. Through his pioneering work on Tris[tetrahydroisoquinoline] compounds, Pachter continues to inspire advancements in medical science and therapeutic interventions, solidifying his legacy as a trailblazer in healthcare innovation.

Would you like to know more about other inventors or patents?

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…